Validated high-performance thin-layer chromatographic method for the quantification of thymoquinone in Nigella Sativa extracts and formulations

Phytochemical Analysis

Volumn 22, Issue 4, 2011, Pages 367-373

  Velho Pereira, Reelma M ^a   Barhate, Chandrashekhar R ^a   Kulkarni, Savita R ^a   Jagtap, Aarti G ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

formulations; herbal extracts; High performance thin layer chromatography; marketed oils; method validation; Nigella sativa; thymoquinone

Indexed keywords

ABSORBANCE; CHROMATOGRAPHIC ANALYSIS; COMMERCE; ESSENTIAL OILS; PLANT EXTRACTS; THIN LAYER CHROMATOGRAPHY; VOLATILE ORGANIC COMPOUNDS;

CHROMATOGRAPHIC METHODS; FORMULATION; HERBAL EXTRACT; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; MARKETED OIL; METHOD VALIDATIONS; NIGELLA SATIVA; PERFORMANCE; THIN LAYERS; THYMOQUINONE;

SILICA GEL;

CYCLOHEXANE; HERBACEOUS AGENT; LIPID; NIGELLA SATIVA EXTRACT; OIL; THYMOQUINONE; TOLUENE;

ARTICLE; BLACK CUMIN; CHROMATOGRAPHY; DENSITOMETRY; DRUG DETERMINATION; DRUG FORMULATION; DRUG STABILITY; ENVIRONMENTAL TEMPERATURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMIT OF DETECTION; NONHUMAN; SENSITIVITY AND SPECIFICITY;

NIGELLA SATIVA;

EID: 79959303373     PISSN: 09580344     EISSN: 10991565     Source Type: Journal    
DOI: 10.1002/pca.1289     Document Type: Article

References (15)

1. Abou Basha L, Rashed MS, Aboul-Enein HY,. 1995. TLC assay of thymoquinone in black seed oil (Nigella sativa Linn) and identification of dithymoquinone and thymol. J Liq Chromatogr Relat Technol 18: 105-115.
2. Ali BH, Blunden G,. 2003. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 17: 299-305. (Pubitemid 36565330)
3. Al-Saleh IA, Billedo G, El-Dough II,. 2006. Levels of selenium dl -α-tocopherol, dl -γ-tocopherol, all-trans-retinol, thymoquinone and thymol in different brands of Nigella sativa seeds. J Food Compos Anal 19: 167-175. (Pubitemid 43024886)
4. Dixit RP, Barhate CR, Nagarsenker MS,. 2008. Stability-indicating HPTLC method for simultaneous determination of ezetimibe and simvastatin. Chromatographia 67: 101-107.
5. El-Dakhakhny M, Madi NJ, Lembert N, Ammon HPT,. 2002. Nigella sativa oil, nigellone and derived thymoquinone inhibit synthesis of 5-lipooxygenase products in polymorphonuclear leukocytes from rats. J Ethnopharmacol 81: 161-164. (Pubitemid 34628498)
6. Gali-Muhtasib HU, Kheir WGA, Kheir LA, Darwiche N, Crooks PA,. 2004. Molecular pathway for thymoquinone-induced cell-cycle arrest and apoptosis in neoplastic keratinocytes. Anticancer Drugs 15: 389-399. (Pubitemid 38526764)
7. Gali-Muhtasib H, Roessner A, Schneider-Stock R,. 2006. Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol 38: 1249-1253.
8. Ghosheh OA, Houdi AA, Crooks PA,. 1999. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J Pharm Biomed Anal 19: 757-762. (Pubitemid 29092778)
9. Houghton PJ, Zarka R, de las Heras B, Hoult JR,. 1995. Fixed oil of Nigella sativa and derived thymoquinone inhibit eicosanoid generation in leukocytes and membrane lipid peroxidation. Planta Med 61: 33-36.
10. ICH. 1996/2005. Q2R1. Validation of Analytical Procedures: Text and Methodology. ICH: Geneva. Available from: (accessed June 2009).
11. Kaur AD, Ravichandran V, Jain PK, Agrawal RK,. 2008. High-performance thin layer chromatography method for estimation of conessine in herbal extract and pharmaceutical dosage formulations. J Pharm Biomed Anal 46: 391-394.
12. Michelitsch A, Rittmannsberger A,. 2003. A simple differential pulse polarographic method for the determination of thymoquinone in black seed oil. Phytochem Anal 14: 224-227. (Pubitemid 36926566)
13. Salem ML,. 2005. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 5: 1749-1770. (Pubitemid 41594584)
14. Tayade NG, Nagarsenker MS,. 2007. Validated HPTLC method of analysis for artemether and its formulations. J Pharm Biomed Anal 43: 839-844. (Pubitemid 46185786)
15. United States Pharmacopeial Convention. 2002. United States Pharmacopeia/The National Formulary (USP24/NF19). United States Pharmacopeial Convention: Rockville, MD; 1393-1395.